These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 30225838

  • 1. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma.
    Abe T, Nakata K, Kibe S, Mori Y, Miyasaka Y, Ohuchida K, Ohtsuka T, Oda Y, Nakamura M.
    Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
    Pointer DT, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, Schell MJ, Hodul PJ, Pimiento JM, Fleming JB, Malafa MP.
    BMC Cancer; 2020 Aug 11; 20(1):750. PubMed ID: 32782024
    [Abstract] [Full Text] [Related]

  • 4. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH, Kim HJ.
    Hepatobiliary Pancreat Dis Int; 2018 Oct 11; 17(5):450-455. PubMed ID: 30237091
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
    Nakagawa K, Sho M, Akahori T, Nagai M, Nakamura K, Takagi T, Tanaka T, Nishiofuku H, Ohbayashi C, Kichikawa K, Ikeda N.
    Pancreatology; 2019 Jul 11; 19(5):722-728. PubMed ID: 31153778
    [Abstract] [Full Text] [Related]

  • 10. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer.
    Chawla A, Huang TL, Ibrahim AM, Hardacre JM, Siegel C, Ammori JB.
    HPB (Oxford); 2018 May 11; 20(5):398-404. PubMed ID: 29221789
    [Abstract] [Full Text] [Related]

  • 11. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T, Amano H, Kobayashi T, Hanada K, Nakahara M, Ohdan H, Noriyuki T.
    Eur J Surg Oncol; 2018 Oct 11; 44(10):1573-1579. PubMed ID: 29807728
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer.
    Asaoka T, Miyamoto A, Maeda S, Tsujie M, Hama N, Yamamoto K, Miyake M, Haraguchi N, Nishikawa K, Hirao M, Ikeda M, Sekimoto M, Nakamori S.
    Pancreatology; 2016 Oct 11; 16(3):434-40. PubMed ID: 26852169
    [Abstract] [Full Text] [Related]

  • 13. Novel immunological and nutritional-based prognostic index for gastric cancer.
    Sun KY, Xu JB, Chen SL, Yuan YJ, Wu H, Peng JJ, Chen CQ, Guo P, Hao YT, He YL.
    World J Gastroenterol; 2015 May 21; 21(19):5961-71. PubMed ID: 26019461
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.
    Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI.
    Am J Surg; 2010 Aug 21; 200(2):197-203. PubMed ID: 20122680
    [Abstract] [Full Text] [Related]

  • 17. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
    Ben Q, An W, Wang L, Wang W, Yu L, Yuan Y.
    Pancreas; 2015 Apr 21; 44(3):471-7. PubMed ID: 25423560
    [Abstract] [Full Text] [Related]

  • 18. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M, Pilarsky E, Kersting S, Grützmann R.
    Int J Surg; 2013 Apr 21; 11(10):1067-72. PubMed ID: 24161419
    [Abstract] [Full Text] [Related]

  • 19. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.
    Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M, Tokuyasu N, Honjo S, Ikeguchi M.
    Surg Today; 2016 Nov 21; 46(11):1258-67. PubMed ID: 26869184
    [Abstract] [Full Text] [Related]

  • 20. Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC).
    Xiang ZJ, Hu T, Wang Y, Wang H, Xu L, Cui N.
    Biosci Rep; 2020 Jun 26; 40(6):. PubMed ID: 32510138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.